Conference Coverage

Sept. 29, 2025 — A new clinical trial report finds that stereotactic radiation therapy offers long-term survival outcomes comparable to surgery for patients with small, early-stage non-small cell lung cancer (NSCLC).

Oct.

Oct. 7, 2025 – Clairity Inc., a leader in AI-based breast cancer risk prediction, will make five scientific presentations featuring its FDA-authorized image-only AI model at the Radiological Society of North America (RSNA) 2025 Annual Meeting, Nov. 30 to Dec. 4 in Chicago.

Sept. 29, 2025 — Radiation therapy may offer a comparable and potentially safer alternative to repeat catheter ablation for patients with severe abnormal heart rhythms that can no longer be controlled with medication.

Sept. 26, 2025 – Accuray Inc. has introduced the Accuray Stellar* solution. Initially for the U.S. market, the new Accuray technology is comprised of a comprehensive tool set designed to empower clinical teams to address the evolving treatment needs of patients undergoing radiotherapy.